Development of machine learning based approaches for identifying new drug targets

Add to your list(s) Download to your calendar using vCal

• Namshik Han, Milner Therapeutics Institute
• Tuesday 20 February 2018, 13:00-14:00
• MR3 Centre for Mathematical Sciences.

If you have a question about this talk, please contact Dr Vivien Gruar.

The aim of the Project is to combine detailed molecular studies with machine learning approaches to understand how genetic and epigenetic factors give rise to unique gene expression patterns in response to human diseases.

To address this, we attempt to utilise the vast wealth of biological data produced by modern large scale genomic projects. Modern experimental techniques allow direct genome-wide measurement of various molecular feature and these measurements are deposited in large scale quantitative databases. However, the complex interactions of multiple genetic and epigenetic factors are hard to determine experimentally. In the absence of such biological experiments, it becomes necessary to utilise systematic analysis methods, including machine learning.

Current state-of-the-art takes existing knowledge and asks “How does this data relate to what we already know?” By applying machine learning approaches the Project will integrate and explore the data to discover new biological knowledge and generate testable hypotheses. The Project is open-ended.

This talk is part of the Cambridge Mathematics Placements Seminars series.

This talk is included in these lists:

• MR3 Centre for Mathematical Sciences

Note that ex-directory lists are not shown.